Cargando…
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Hydrogen sulfide (H(2)S) has been known for years as a poisoning gas and until recently evoked mostly negative associations. However, the discovery of its gasotransmitter functions suggested its contribution to various physiological and pathological processes. Although H(2)S has been found to exert...
Autores principales: | Kaziród, Katarzyna, Myszka, Małgorzata, Dulak, Józef, Łoboda, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705465/ https://www.ncbi.nlm.nih.gov/pubmed/36441348 http://dx.doi.org/10.1007/s00018-022-04636-0 |
Ejemplares similares
-
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
por: Mucha, Olga, et al.
Publicado: (2021) -
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
por: Łoboda, Agnieszka, et al.
Publicado: (2020) -
Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019) -
Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
por: Mucha, Olga, et al.
Publicado: (2021) -
Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2021)